This article will address the topic of Stepholidine, which has gained great relevance in recent years, due to its impact on various areas of society. Since its appearance, Stepholidine has aroused great interest and generated intense debates in public opinion. Throughout this research, the different aspects related to Stepholidine will be analyzed, as well as its implications in different contexts. The current and future perspectives of Stepholidine will also be addressed, in order to provide a comprehensive vision of this currently significant topic.
![]() | |
Names | |
---|---|
IUPAC name
3,9-Dimethoxyberbine-2,10-diol
| |
Systematic IUPAC name
(13aS)-3,9-Dimethoxy-5,8,13,13a-tetrahydro-6H-isoquinolinoisoquinoline-2,10-diol | |
Other names
l-Stepholidine
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
MeSH | Stepholidine |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C19H21NO4 | |
Molar mass | 327.374 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).
|
(−)-Stepholidine is a protoberberine alkaloid found in the plant Stephania intermedia.
Stepholidine activity includes dual D2 receptor antagonist and D1 receptor agonist, and has shown antipsychotic activity in animal studies.[1][2][3][4]